A newly-released report from Pharmaceutical Research and Manufacturers of America (PhRMA) has revealed that 28 new medications are in development to treat epilepsy and seizures.
But that’s just the tip of the iceberg.
These 28 new drugs are among nearly 420 new ground-breaking medicines in progress to treat neurological disorders.
Of the 28 epilepsy medicines listed in the report, seven are in or have completed phase one of development, eight are in or have completed phase two and, thirteen are in or have completed phase three.
The large number of drugs currently in clinical trials provides a measure of hope for patients whose epilepsy is not controlled with currently available medication.
In the future, this range of antiepileptic drugs will probably increase because of the use of new animal models, discovery of new basic mechanisms of epileptogenesis, acceleration of proof of principle studies in people, and development of new methods…
View original post 255 more words